Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Management of Hypertensive Emergencies Dr. Abdulkareem Alsuwiada, FRCPC, MSc Learning Objectives To identify and triage severe hypertensive states accurately To effectively manage hypertensive crises with drug therapy Hypertensive Urgency “Severe elevation of blood pressure” Generally DBP >115-130 No progressive end organ damage Hypertensive Emergency Hypertensive Emergency: Severe elevation in blood pressure in the presence of acute or ongoing end-organ damage. “Recognition of hypertensive emergency depends on the clinical state of the patient, not on the absolute level of blood pressure” Target Organs Hypertensive Emergency Key Points Cardiac Emergencies • • • Acute CHF Acute coronary insufficiency Aortic dissection Hypertensive Emergency Key Points CNS Emergencies Hypertensive encephalopathy Intracerebral or subarachnoidal hemorrhage Thrombotic brain infarction with severe HTN Hypertensive Emergency Key Points Renal Emergencies Rapidly progressive renal failure Fundoscopy/ Neuro • Hemorrhages • Exudates • Papillodema Urgency vs. Emergency Distinguishing between hypertensive emergency and urgency is a crucial step in appropriate management Urgency vs. Emergency Urgency No need to acutely lower blood pressure May be harmful to rapidly lower blood pressure Death not imminent Emergency Immediate control of BP essential Irreversible end organ damage or death within hours Approach to Patients Approach to patients Recheck blood pressure! Appropriate size cuff Cuff not over clothing Check in all limbs History Prior crises Renal disease Medications Compliance Recreational drugs Approach to patients Physical Exam Signs of end organ damage? Neuro Hypertensive encephalopathy Severe Headache Nausea/Vomiting Papilledema Visual Changes Seizures Focal Neurological Deficits Ischemic vs hemorrhagic CVA Fundoscopy/ Neuro Cardiac Cardiac ischemia Chest pain EKG for ischemic changes Acute left ventricular failure Pulmonary edema Hypoxia EKG for left ventricular strain pattern CXR Renal Electrolytes BUN/Cr Chronic failure/insufficiency vs acute failure Cause vs effect UA with micro Protein Blood Casts Major Causes of Hypertensive Emergencies and Urgencies Untreated essential hypertension Withdrawal / non-adherence to antihypertensive drug therapy Development of secondary hypertension Major Causes of Hypertensive Emergencies and Urgencies Renal Disease Renal artery stenosis Pregnancy Endorine Pheochromocytoma Primary aldosteronism Glucocorticoid excess Renin-secreting tumors Pathogenesis for Hypertension Arterial and arteriolar vasoconstriction Prevents the increase in pressure from being transmitted to the smaller, more distal vessels With increasingly severe hypertension Autoregulation failure Vascular endothelial injury Plasma constituents (including fibrinoid material) to enter the vascular wall narrowing or obliterating the vascular lumen. Tissue edema and activation of endothelial vasoactive system Goals of Treatment Goals of Treatment Prevent end organ damage NOT normalize BP Exceptions?? HTN Urgencies: Goals of Therapy No proven benefit of rapid BP reduction in asymptomatic patients Goal BP <160/110 mm Hg over several hours, oral therapy Initial BP fall less than 25% in first six hours can be managed using oral antihypertensive agents in an outpatient or same-day observational setting Ensure follow-up: Long-term management HTN Urgencies: Therapy Captopril , 25-mg oral dose initially, followed by incremental doses of 50 to 100 mg 90 to 120 min later The calcium channel blocker nicardipine, 30 mg, q 8 hours until the target BP Labetolol, the starting dose is 200 mg orally, which can be repeated every 3 to 4 hours Clonidine is a central sympatholytic a 0.1 to 0.2 mg loading dose followed by 0.05 to 0.1 mg every hour until target BP is achieved (Max 0.7 mg). Hypertensive Emergency ICU with close monitoring IV and Short acting medications Avoid sublingual or IM Arterial line Goals of Treatment Within 1-2 hrs Lower MAP 20-25% CONTROLLED IV titratable meds Complications for rapid BP Reduction in Severe Hypertension Widening Neurologic Deficits Retinal ischemia and Blindness Acute MI Deteriorating renal function Goals of Treatment WHY ? Cerebral Autoregulation Strandgaard, et al. BMJ: 1973 Cerebral blood flow 60 mmHg 120 mmHg MAP Adapted from: Chest, 2000; 118:214-227 160 mmHg Pharmacotherapy Antihypertensive Drugs for Hypertensive Crisis Given by continuous infusion Sodium nitroprusside Nitroglycerin Nicardipine Labetalol Esmolol Fenoldapam Specific Treatment Hypertensive Encephalopathy Nitroprusside • Fenoldopam Nicardipine Labetolol Symptoms of encephalopathy should improve with treatment CVA Nicardipine Labetolol Fenoldopam Decrease DBP no more than 20% in 24hrs Cardiac Ischemia Nitroglycerine Nitroprusside • Fenoldopam Nifedipine Reflex tachy Increases myocardial O2 demand May aggravate ischemia Acute LVF Nitroprusside Afterload reduction Nitroglycerine If ischemia is suspected Furosemide Fenoldopam Loop diuretic Opioids Acute Aortic Dissection Nitroprusside • Nicardipine, Fenoldopam Afterload reduction Increases ventricular contraction velocity Requires B blockade Esmolol, metoprolol Labetolol Goal: SBP ~100 mmHg Monitor patient closely Acute Aortic Dissection β-block FIRST! Esmolol Metoprolol Sympathetic Crisis Nicardipine Nitroprusside Phentolamine Acute Renal Failure Nicardipine Nitroprusside “Use with caution” toxic metabolites... Thiocyanate excreted via kidneys Fenoldopam Labetolol Eclampsia Hydralazine Used historically Arterial vasodilator Maintains placental blood flow Nicardipine Labetolol Magnesium The Discharged Patient The discharged patient JNC-VII Recommendations Stage 2 Combination tx Thiazide + ACEI, ARB, BB, CCB “Compelling Indications”... The discharged patient JNC-VII Recommendations “Compelling Indications” URGENCY: ALL PATIENTS WITH HTN URGENCY BEING DISCHARGED HOME SHOULD BE PLACED ON COMBINATION THERAPY AND HAVE RAPID FOLLOW UP. THIAZIDE ACEI / ARB / BB / CCB The discharged patient Follow up... Stage I: Stage II: 140-159 / or 90-99 >160 / or ≥100 Follow-up 2 Months 1 Months “Higher”: ≥180 / ≥110 < 1 week Goals of therapy in JNC7 & Euro Guidelines Maximum reduction in long-term total risk of cardiovascular morbidity and mortality: Smoking Life style modification Lipid Diabetes Blood pressure < 140/90 If DM or renal disease <130/80 The following 5 patients in ER Patient A is a 65-year-old man with nausea, vomiting, and confusion. Patient B is a 73-year-old woman with sudden shortness of breath, pink sputum, and heavy chest pain. Patient C is a 56-year-old man with sharp, tearing chest and back pain. Patient D is a 64-year-old woman with a 6-hour history of right-sided weakness. Patient E is a 51-year-old woman with a mild headache, concerned about her history of hypertension. all 5 patients arrive with identical vital signs: BP of 209/105 mm Hg Which of the 5 patients require emergent hypertension treatment? Patient A is a 65-year-old man with nausea, vomiting, and confusion. Hypertensive encephalopathy Pure vasodilators like nitroprusside have risks of intracranial shunting, which could increase intracranial pressure. Drug of choice: Intravenous labetalol, bolus or infusion. Target: Reduce MAP by 20% to 25% over 2 to 8 hours. Patient B: 73-year-old woman with sudden shortness of breath, pink sputum, and heavy chest pain. Physical examination reveals bilateral crackles in her lungs, an elevated JVP, and no heart murmurs. Acute pulmonary edema often presents with extreme hypertension, which overloads cardiac reserve. Drug of choice: Nitroglycerin infusion; IV enalaprilat or sublingual captopril. Target: Reduce MAP by 20% to 25% and symptomatic improvement. Patient C: 56-year-old man with sharp, tearing chest and back pain. Physical examination reveals differential BPs and evidence of a new aortic insufficiency murmur. Aortic dissection is largely a disease of hypertension. Drug of choice: Nitroprusside or esmolol infusion;labetalol boluses or infusion. Target: Rapidly reduce systolic BP to 110 mm Hg if there is no evidence of hypoperfusion. Patient D: 64-year-old woman with a 6hour history of right-sided weakness. Marked right-sided hemiplegia is noted. a higher MAP is essential to maintaining adequate cerebral blood flow and not extending the affected stroke territory. BP should not be lowered in the acute period except in extreme situations BP > 220/120 mm Hg in embolic CVA > 180/100 in hemorrhagic CVA Patient D: 64-year-old woman with a 6hour history of right-sided weakness. Drug of choice: Labetalol; nicardipine; hydralazine. Target: If no thrombolytic is given, reduce BP only if it is greater than 220/120 mm Hg (embolic) or greater than 180/100 mm Hg (hemorrhagic) If a thrombolytic is given, reduce BP to 180/100 mm Hg. Patient E: 51-year-old woman with a mild headache, concerned about her history of hypertension. These patients require gradual BP reduction over time on an outpatient basis Summary Accurate history and timeline of onset Evaluate Target organ injury Set the time frame for intervention Appropriate “pace” of therapy Initial reduction Stabilization Follow-up care/ Diagnostic studies Questions... Comments…